Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

Table of Contents

September 2022; Volume 42,Issue 9

Reviews

  • Open Access
    Craniopharyngiomas Invading the Ventricular System: A Systematic Review
    PAOLO PALMISCIANO, KURTIS YOUNG, MAYA OGASAWARA, OMID YOUSEFI, CHRISTIAN OGASAWARA, GIANLUCA FERINI, OTHMAN BIN-ALAMER, MAYUR SHARMA, GIUSEPPE E. UMANA, KENNY YU, AARON A. COHEN-GADOL, TAREK Y. EL AHMADIEH and ALI S. HAIDER
    Anticancer Research September 2022, 42 (9) 4189-4197; DOI: https://doi.org/10.21873/anticanres.15919
  • Open Access
    Applicability of a Host-mediated In Vivo/In Vitro Model in Screening for the Carcinogenic Potential of Chemicals
    KATHRIN SCHLATTERER, ANOOSH ESMAEILI, THOMAS MASSA, SAVVAS APOSTOLIDIS and PRAKASH CHANDRA
    Anticancer Research September 2022, 42 (9) 4199-4206; DOI: https://doi.org/10.21873/anticanres.15920
  • You have access
    Screening for Ovarian Cancer in the General Population: State of Art and Perspectives of Clinical Research
    ANGIOLO GADDUCCI and STEFANIA COSIO
    Anticancer Research September 2022, 42 (9) 4207-4216; DOI: https://doi.org/10.21873/anticanres.15921
  • Open Access
    Comparison of Proportion of Elevated Carcinoembryonic Antigen Levels in Patients With Appendiceal and Colorectal Adenocarcinoma: A Systematic Review and Meta-analysis
    ADAM T. CRISTAUDO, SCOTT B. JENNINGS and DAVID L. MORRIS
    Anticancer Research September 2022, 42 (9) 4217-4235; DOI: https://doi.org/10.21873/anticanres.15922
  • You have access
    Epithelial to Mesenchymal Transition in Lung Cancer: Potential EMT-Targeting Natural Product-derived Compounds
    PITHI CHANVORACHOTE, KORRAKOD PETSRI and SUNISA THONGSOM
    Anticancer Research September 2022, 42 (9) 4237-4246; DOI: https://doi.org/10.21873/anticanres.15923
  • You have access
    Evidence of Potential Plant-derived Compounds With Anticancer Effects on Lung Cancer: Clinical and Molecular Pharmacology Approaches
    MONRUEDEE SUKPRASANSAP and PITHI CHANVORACHOTE
    Anticancer Research September 2022, 42 (9) 4247-4258; DOI: https://doi.org/10.21873/anticanres.15924

Experimental Studies

  • Open Access
    Establishment of Cytotoxic and Non-cytotoxic NK-92 Cell Clones – Evaluation of Their Function as Target Cells
    HANS BERGMAN, ELINDA HERMANSON and CHRISTER LINDQVIST
    Anticancer Research September 2022, 42 (9) 4259-4264; DOI: https://doi.org/10.21873/anticanres.15925
  • You have access
    Etoposide-induced MicroRNA-205-5p Suppresses Proliferation and Migration by Targeting ERBB4 in MCF-7 Cells
    SEUNG WAN SON, SEUNG HYEOK HEO, SANG SU OH, CHAN HEE LEE and JONG KOOK PARK
    Anticancer Research September 2022, 42 (9) 4265-4272; DOI: https://doi.org/10.21873/anticanres.15926
  • You have access
    Study of the Acquisition of Sensitivity to Paclitaxel Plus Cetuximab by the Addition of Low-dose Proteasome Inhibitor
    MASAKI YODA, KANAME SAKUMA, TOMOYUKI KII and AKIRA TANAKA
    Anticancer Research September 2022, 42 (9) 4273-4283; DOI: https://doi.org/10.21873/anticanres.15927
  • You have access
    Effects of Mixed Nuts on Colonic Cell Proliferation and Ptgs2 and Rela Gene Expression
    MEE YOUNG HONG, JEFF MOORE, ASHLEY NAKAGAWA and VANESSA NUNGARAY
    Anticancer Research September 2022, 42 (9) 4285-4292; DOI: https://doi.org/10.21873/anticanres.15928
  • You have access
    An In Vivo Study of Local Administration of Low-dose Anti-PD-1 Antibody Using an Oral Cancer Cell Line
    KANAME SAKUMA, TOMOYUKI KII, HARUKA TAKAHASHI, SUSUMU SUZUKI, KAZUHIRO YOSHIKAWA, TETSUYA OGAWA and AKIRA TANAKA
    Anticancer Research September 2022, 42 (9) 4293-4303; DOI: https://doi.org/10.21873/anticanres.15929
  • Open Access
    Verification of A New Filter for Isolation of Circulating Tumor Cells by Only Blood Filtration
    KOHEI MORITA, NORIYOSHI SAWABATA, SHIGENOBU TATSUMI, TOMOMI FUJII, TAKASHI NISHIKAWA, TAKESHI KAWAGUCHI, TORU ARAKANE, YOSHIAKI TOMINAGA, HIROKAZU SAKAGUCHI, TARO KOBAYASHI, SHIGETO HONTSU, YOSHIFUMI YAMAMOTO, NOBUHIRO FUJIOKA, NORIKO OUJI-SAGESHIMA, TOSHIHIRO ITO and CHIHO OHBAYASHI
    Anticancer Research September 2022, 42 (9) 4305-4310; DOI: https://doi.org/10.21873/anticanres.15930
  • You have access
    The γ-Glutamylcyclotransferase Inhibitor Pro-GA Induces an Antiproliferative Effect Through the Generation of Mitochondrial Reactive Oxygen Species
    HIROMI II, KEIKO TANIGUCHI, TAKU YOSHIYA, YUKIE NOHARA, SUSUMU KAGEYAMA, AKIHIRO KAWAUCHI and SUSUMU NAKATA
    Anticancer Research September 2022, 42 (9) 4311-4317; DOI: https://doi.org/10.21873/anticanres.15931
  • You have access
    Compound Library Screening for Synergistic Drug Combinations: mTOR Inhibitor and Proteasome Inhibitor Effective Against Osteosarcoma Cells
    KUNIHIRO ASANUMA, TOMOKI NAKAMURA, KOICHI NAKAMURA, TOMOHITO HAGI, TAKAYUKI OKAMOTO, KOUJI KITA, YUMI MATSUYAMA, KEISUKE YOSHIDA, YUMIKO ASANUMA and AKIHIRO SUDO
    Anticancer Research September 2022, 42 (9) 4319-4328; DOI: https://doi.org/10.21873/anticanres.15932
  • Open Access
    The Contribution of Flap Endonuclease 1 Genotypes to Oral Cancer Risk
    SHIH-HAN PAN, WEI-CHING CHIEN, JIE-LONG HE, LIANG-CHUN SHIH, CHE-LUN HSU, TE-CHUN HSIA, YUN-CHI WANG, HAO-YUAN TSAO, CHIA-WEN TSAI, DA-TIAN BAU and WEN-SHIN CHANG
    Anticancer Research September 2022, 42 (9) 4329-4335; DOI: https://doi.org/10.21873/anticanres.15933
  • You have access
    Neuroectodermal Rosettes in Immature Teratomas Are Not the Counterpart of Embryonal Tumours With Multilayered Rosettes
    NAOMI MAGARIFUCHI, YUICHI YAMADA, YOSHIHIRO OISHI, KIYOKO KATO, KENICHI TAGUCHI and YOSHINAO ODA
    Anticancer Research September 2022, 42 (9) 4337-4344; DOI: https://doi.org/10.21873/anticanres.15934
  • You have access
    Aptamer-cocktail Functionalized Nano-microfluidic Chip for Enhancing Isolation and Characterization of Circulating Cancer Cells
    MIN LI, DAN LIU, JIAN ZHANG, XIUMING ZHANG and XIAOWEN DOU
    Anticancer Research September 2022, 42 (9) 4345-4358; DOI: https://doi.org/10.21873/anticanres.15935
  • You have access
    Implication of IL6-positive Cancer-associated Fibroblasts in Merkel Cell Carcinoma Pathogenesis: A Possible Modulator of Immune Microenvironment
    ZHENLONG ZHENG, DAE SAN YOO, SHANSHAN LI, MEILING PEI, SANG GYUN LEE, JI YOUNG KIM, KEE YANG CHUNG and MI RYUNG ROH
    Anticancer Research September 2022, 42 (9) 4359-4369; DOI: https://doi.org/10.21873/anticanres.15936
  • Open Access
    Two-Phase Deep Learning Algorithm for Detection and Differentiation of Ewing Sarcoma and Acute Osteomyelitis in Paediatric Radiographs
    SARAH CONSALVO, FLORIAN HINTERWIMMER, JAN NEUMANN, MARC STEINBORN, MAYA SALZMANN, FRITZ SEIDL, ULRICH LENZE, CAROLIN KNEBEL, DANIEL RUECKERT and RAINER H.H. BURGKART
    Anticancer Research September 2022, 42 (9) 4371-4380; DOI: https://doi.org/10.21873/anticanres.15937
  • You have access
    Genetic and Transcriptional Analysis of 8q24.21 Cluster in Gastric Cancer
    BRUNNO SANTOS PEREIRA, FERNANDA WISNIESKI, DANIELLE QUEIROZ CALCAGNO, LEONARDO CAIRES SANTOS, CAROLINA OLIVEIRA GIGEK, ELIZABETH SUCHI CHEN, LUCAS TREVIZANI RASMUSSEN, SPENCER LUIZ MARQUES PAYÃO, RENATA SANCHES ALMEIDA, CAMILA ALBUQUERQUE PINTO, BRUNO TAKAO REAL KARIA, RICARDO ARTIGIANI, SAMIA DEMACHKI, PAULO PIMENTEL ASSUMPÇÃO, LAERCIO GOMES LOURENÇO, CARLOS HARUO ARASAKI, ROMMEL RODRÍGUEZ BURBANO, MARIANA FERREIRA LEAL and MARILIA ARRUDA CARDOSO SMITH
    Anticancer Research September 2022, 42 (9) 4381-4394; DOI: https://doi.org/10.21873/anticanres.15938
  • You have access
    The Effect of Trimetazidine on Diathermy-related Thermic Injury of the Rat Liver
    SANDOR FERENCZ, ANDRAS PALKOVICS, ANDRAS FINCSUR, ANDRAS VERECZKEI, ILDIKO TAKACS, BALAZS NEMETH and ANDRAS PAPP
    Anticancer Research September 2022, 42 (9) 4395-4401; DOI: https://doi.org/10.21873/anticanres.15939
  • You have access
    Magnolol Suppresses ERK/NF-κB Signaling and Triggers Apoptosis Through Extrinsic/Intrinsic Pathways in Osteosarcoma
    CHI-HUAN LI, MING-CHOU KU, KUN-CHING LEE, PO-FU YUEH, FEI-TING HSU, RONG-FONG LIN, CHUNG-CHI YANG, WEI-CHUN WANG, JIANN-HWA CHEN, LI-CHO HSU and YUAN-HAO LEE
    Anticancer Research September 2022, 42 (9) 4403-4410; DOI: https://doi.org/10.21873/anticanres.15940
  • You have access
    Irradiation Methods for Accurate Dose Delivery to Postoperative Keloid Scars With Minimal Normal Tissue Exposure Using TomoTherapy: A Phantom Study
    KATSUYA OKUHATA, KENTA KIJIMA, KENJI NAKAMURA, YUYA YANAGI and HAJIME MONZEN
    Anticancer Research September 2022, 42 (9) 4411-4415; DOI: https://doi.org/10.21873/anticanres.15941

Clinical Studies

  • Open Access
    Immunological and Genetic Characterization of Patients With Head and Neck Cancer who Developed Recurrence
    KAZUAKI YASUI, RYOTA KONDOU, HARUO MIYATA, AKIRA IIZUKA, TADASHI ASHIZAWA, TAKESHI NAGASHIMA, KEIICHI OHSHIMA, KENICHI URAKAMI, KOJI MURAMATSU, TAKASHI SUGINO, KEN YAMAGUCHI, HIROFUMI OGAWA, TSUYOSHI ONOE, HIDEYUKI HARADA, HIROFUMI ASAKURA, SHIGEYUKI MURAYAMA, TETSUO NISHIMURA, SEIYA GOTO, SHINICHI OKADA, TAKASHI MUKAIGAWA, SATOSHI HAMAUCHI, TOMOYA YOKOTA, YUSUKE ONOZAWA and YASUTO AKIYAMA
    Anticancer Research September 2022, 42 (9) 4417-4428; DOI: https://doi.org/10.21873/anticanres.15942
  • You have access
    Survivorship Care Plans Improve the Identification of Post-radiation Hypothyroidism After Head and Neck Cancer Treatment
    ZVONIMIR L. MILAS, BRITTANY NEELANDS, SALLY J. TRUFAN, JENNIFER BENBOW, DANIEL CARRIZOSA, DANIEL S. BRICKMAN, CATHERINE H. FRENKEL, ASHLEY L. SUMRALL, SHWETHA M. SUDHAKAR and MATTHEW C. WARD
    Anticancer Research September 2022, 42 (9) 4429-4437; DOI: https://doi.org/10.21873/anticanres.15943
  • Open Access
    Analyses of Ocular Adverse Reactions Associated With Anticancer Drugs Based on the Japanese Pharmacovigilance Database
    JUNKO TANAKA, TAKENAO KOSEKI, MASASHI KONDO, YASUKI ITO and SHIGEKI YAMADA
    Anticancer Research September 2022, 42 (9) 4439-4451; DOI: https://doi.org/10.21873/anticanres.15944
  • You have access
    Assessing Resection Margin Status in Breast-conserving Surgery Specimens: Comparison Among Gross Evaluation, Frozen Section Analysis, and Permanent Section Diagnosis in 725 Patients With Breast Cancer
    JEONGEUN DO, JINAH CHU, JAEYOUNG AHN, GO EUN BAE, SANG HWA LEE, HYUN-SOO KIM and SUNG-IM DO
    Anticancer Research September 2022, 42 (9) 4453-4460; DOI: https://doi.org/10.21873/anticanres.15945
  • You have access
    Expanding Sorafenib Treatment for Hepatocellular Carcinoma Beyond Barcelona Clinic Liver Cancer Stage C Patients: A National Study
    CHING-TSO CHEN, CHIH-HUNG HSU, ANN-LII CHENG and YU-YUN SHAO
    Anticancer Research September 2022, 42 (9) 4461-4470; DOI: https://doi.org/10.21873/anticanres.15946
  • Open Access
    Surgical Strategies to Approaching the Splenic Artery in Robotic Distal Pancreatectomy
    KOSEI TAKAGI, KENJIRO KUMANO, YUZO UMEDA, RYUICHI YOSHIDA, TOMOKAZU FUJI, KAZUYA YASUI, TAKAHITO YAGI and TOSHIYOSHI FUJIWARA
    Anticancer Research September 2022, 42 (9) 4471-4476; DOI: https://doi.org/10.21873/anticanres.15947
  • Open Access
    Real-world Therapeutic Outcomes of the Pembrolizumab Regimen as First-line Therapy for Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck: A Single-center Retrospective Cohort Study in Japan
    DAISUKE SANO, MOTOHIKO TOKUHISA, HIDEAKI TAKAHASHI, TAKASHI HATANO, GOSHI NISHIMURA, YASUSHI ICHIKAWA and NOBUHIKO ORIDATE
    Anticancer Research September 2022, 42 (9) 4477-4484; DOI: https://doi.org/10.21873/anticanres.15948
  • You have access
    Intraoperative Brachytherapy Combined With Adjuvant Radiotherapy Shows Equal Results in the Treatment of Leiomyosarcoma on the Extremities Compared to Adjuvant Radiotherapy Only – A Multicentric Retrospective Analysis
    DIETMAR DAMMERER, ANNELIES VAN BEECK, KATRIN WABRO, KAREN BLOCKHUYS and JOZEF MICHIELSEN
    Anticancer Research September 2022, 42 (9) 4485-4492; DOI: https://doi.org/10.21873/anticanres.15949
  • Open Access
    Crypts in Asymmetric Branching in Patients With Ulcerative Colitis in Remission
    CARLOS A. RUBIO, MICHAEL VIETH and CORINNA LANG-SCHWARZ
    Anticancer Research September 2022, 42 (9) 4493-4497; DOI: https://doi.org/10.21873/anticanres.15950
  • You have access
    Improved Outcome in Pediatric Acute Myeloid Leukemia: Progress With Hematopoietic Cell Transplantation
    JOANNA STANKIEWICZ and JAN STYCZYNSKI
    Anticancer Research September 2022, 42 (9) 4499-4504; DOI: https://doi.org/10.21873/anticanres.15951
  • You have access
    Treosulfan-based Reduced-intensity Allogeneic Hematopoietic Cell Transplantation in Adults With Primary Immunodeficiency: A Case Series
    VERA DALLA VIA, ANNE STELMES, MIKE RECHER, CHRISTIAN ARRANTO, TILL JUNKER, FRANCESCA MATTEAZZI, DOMINIK HEIM, JAKOB R. PASSWEG, MICHAEL MEDINGER and JANA VAN DEN BERG
    Anticancer Research September 2022, 42 (9) 4505-4509; DOI: https://doi.org/10.21873/anticanres.15952
  • Open Access
    Evaluation of Sleep Disturbances in Patients With Bladder Cancer Scheduled for Local or Loco-regional Radiochemotherapy
    DIRK RADES, SVENJA KOPELKE, STEVEN E. SCHILD, TROELS W. KJAER, SOEREN TVILSTED and TOBIAS BARTSCHT
    Anticancer Research September 2022, 42 (9) 4511-4515; DOI: https://doi.org/10.21873/anticanres.15953
  • You have access
    Predicting Long-term Survival After Lung Metastasectomy in Patients With Malignant Germ-cell Tumors
    MIRCEA GABRIEL STOLERIU, GEORGIOS STATHOPOULOS, ELVIRA STACHER-PRIEHSE, CHRISTIAN KETSCHER, UWE GRÜTZNER, JAN FERTMANN, CHRISTIAN SCHNEIDER, RUDOLF HATZ, NICOLE STROBL and GERHARD PREISSLER
    Anticancer Research September 2022, 42 (9) 4517-4527; DOI: https://doi.org/10.21873/anticanres.15954
  • Open Access
    Sleep Problems Prior to Radio-chemotherapy in Patients With Locally Advanced Cancer of the Esophagus or the Esophagogastric Junction
    DIRK RADES, SVENJA KOPELKE, STEVEN E. SCHILD, SOEREN TVILSTED, TROELS W. KJAER and TOBIAS BARTSCHT
    Anticancer Research September 2022, 42 (9) 4529-4533; DOI: https://doi.org/10.21873/anticanres.15955
  • You have access
    Molecular Characteristics of Metastatic Lesions Have Superior Prognostic Impact on Endometrial Cancer
    KAZUHIRO OKAMOTO, KEIICHIRO NAKAMURA, JUNKO HARAGA and HISASHI MASUYAMA
    Anticancer Research September 2022, 42 (9) 4535-4543; DOI: https://doi.org/10.21873/anticanres.15956
  • You have access
    Clinical Impact of Surgical Sarcopenia on Long-term Survival
    KEISUKE KOMORI, KAZUKI KANO, TORU AOYAMA, KENTARO HARA, SHINSUKE NAGASAWA, MASATO NAKAZONO, YOTA SHIMODA, YUKIO MAEZAWA, YUTA KUMAZU, TAIICHI KAWABE, MASAKATSU NUMATA, TSUTOMU HAYASHI, TAKANOBU YAMADA, HIROSHI TAMAGAWA, TSUTOMU SATO, HARUHIKO CHO, NORIO YUKAWA, YASUSHI RINO, TAKAKI YOSHIKAWA, TAKASHI OGATA and TAKASHI OSHIMA
    Anticancer Research September 2022, 42 (9) 4545-4552; DOI: https://doi.org/10.21873/anticanres.15957
  • You have access
    Prognostic Value of Repeat Hepatectomy for Hepatocellular Carcinoma Patients
    ATSUSHI NANASHIMA, YUKINORI TANOUE, MASAHIDE HIYOSHI, NAOYA IMAMURA, KOICHI YANO, TAKEOMI HAMADA, EIJI KITAMURA, KENGO KAI, KOUSEI TAHIRA and TAKESHI NAGAYASU
    Anticancer Research September 2022, 42 (9) 4553-4561; DOI: https://doi.org/10.21873/anticanres.15958
  • You have access
    Comparison of Microwave and Radiofrequency Ablation in the Treatment of Pulmonary Metastasis of Colorectal Cancer
    CHARIS TAN, OLIVER M. FISHER, LINNA HUANG, NAYEF ALZAHRANI, WINSTON LIAUW, DEREK GLENN and DAVID L. MORRIS
    Anticancer Research September 2022, 42 (9) 4563-4571; DOI: https://doi.org/10.21873/anticanres.15959
  • You have access
    Improved Survival of Real-world Japanese Patients With Advanced Renal Cell Carcinoma Treated With Immuno-oncology Combination Therapy
    KOSUKE UEDA, SHIGETAKA SUEKANE, HIROFUMI KUROSE, NAOKI ITO, NAOYUKI OGASAWARA, TASUKU HIROSHIGE, KATSUAKI CHIKUI, KAZUHISA EJIMA, KEIICHIRO UEMURA, MAKOTO NAKIRI, KIYOAKI NISHIHARA, MITSUNORI MATSUO and TSUKASA IGAWA
    Anticancer Research September 2022, 42 (9) 4573-4580; DOI: https://doi.org/10.21873/anticanres.15960
  • You have access
    Association Between Peripheral Neuropathy Induced by Oxaliplatin at First-line Chemotherapy and Efficacy of Paclitaxel at Second-line Chemotherapy in Patients With Advanced Gastric Cancer
    HIRONORI FUJII, SHIORI SADAKA, KANAE AJISAWA, NAOKI OKUMURA, AKITAKA MAKIYAMA, HIROTOSHI IIHARA, ITARU YASUFUKU, KOICHI OHATA, RYO KOBAYASHI, YOSHIHIRO TANAKA, HIDEKI HAYASHI and AKIO SUZUKI
    Anticancer Research September 2022, 42 (9) 4581-4588; DOI: https://doi.org/10.21873/anticanres.15961
  • You have access
    Discontinuation of Immune Checkpoint Inhibitor and Survival in Patients With Non-small-cell Lung Cancer Without a Driver Gene Mutation
    SOU HATTORI, SHINICHIRO OKAUCHI, YUIKA SASATANI, GEN OHARA, KUNIHIKO MIYAZAKI, SHINYA SATO, TAKAHIDE KODAMA, TOSHIHIRO SHIOZAWA, HIROAKI SATOH and NOBUYUKI HIZAWA
    Anticancer Research September 2022, 42 (9) 4589-4595; DOI: https://doi.org/10.21873/anticanres.15962
  • You have access
    Detection Ability of 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography for Clinical T Classification of Synchronous Esophageal Cancer in Pharyngeal Cancer
    HIDENORI TSUZUKI, HIDENORI SUZUKI, TSUNEO TAMAKI, MICHIHIKO SONE and NOBUHIRO HANAI
    Anticancer Research September 2022, 42 (9) 4597-4602; DOI: https://doi.org/10.21873/anticanres.15963
  • You have access
    Efficacy and Safety of Platinum Rechallenge in Patients With Platinum-resistant Ovarian, Fallopian Tube or Primary Peritoneal Cancer: A Multicenter Retrospective Study
    SHUNSUKE TATSUKI, TADAHIRO SHOJI, MARINA ABE, HIDETOSHI TOMABECHI, ERIKO TAKATORI, YOSHITAKA KAIDO, TAKAYUKI NAGASAWA, MASAHIRO KAGABU, TAKESHI AIDA and TSUKASA BABA
    Anticancer Research September 2022, 42 (9) 4603-4610; DOI: https://doi.org/10.21873/anticanres.15964
  • You have access
    Impact of GLIM Defined Malnutrition on Long Term Prognosis in Patients With Gastric Cancer After Gastrectomy
    RYOTA MATSUI, NORIYUKI INAKI and TOSHIKATSU TSUJI
    Anticancer Research September 2022, 42 (9) 4611-4618; DOI: https://doi.org/10.21873/anticanres.15965
  • You have access
    Clinical Outcomes of Limb-sparing Tumor Surgery With Vascular Reconstruction for Bone and Soft-tissue Tumors
    YOHEI ASANO, NORIO YAMAMOTO, KATSUHIRO HAYASHI, AKIHIKO TAKEUCHI, SHINJI MIWA, KENTARO IGARASHI, YUTA TANIGUCHI, SEI MORINAGA, KAORU TADA, TAKAYUKI NOJIMA and HIROYUKI TSUCHIYA
    Anticancer Research September 2022, 42 (9) 4619-4626; DOI: https://doi.org/10.21873/anticanres.15966
  • You have access
    Endocervical Adenocarcinoma: Comprehensive Histological Review and Re-classification of 123 Consecutive Cases According to the Updated World Health Organization Classification of Female Genital Tumors
    YURIMI LEE, HYUNSIK BAE and HYUN-SOO KIM
    Anticancer Research September 2022, 42 (9) 4627-4639; DOI: https://doi.org/10.21873/anticanres.15967
  • You have access
    First-ever Clinical Experience With Magnetic Resonance-based Lattice Radiotherapy for Treating Bulky Gynecological Tumors
    GIANLUCA FERINI, VITO VALENTI, ANNA VIOLA, GIUSEPPE EMMANUELE UMANA, SALVATORE IVAN ILLARI, SILVANA PARISI, ANTONIO PONTORIERO and STEFANO PERGOLIZZI
    Anticancer Research September 2022, 42 (9) 4641-4646; DOI: https://doi.org/10.21873/anticanres.15968
  • You have access
    Pheochromocytoma Turned Malignant During Pregnancy in a Patient With Neurofibromatosis Type I - A Case Report and Systematic Review of the Current Literature
    CORNELIA ZEITLER, LENA FUDERER, KATJA SCHMITZ, ROHIT ARORA and DIETMAR DAMMERER
    Anticancer Research September 2022, 42 (9) 4647-4656; DOI: https://doi.org/10.21873/anticanres.15969

Corrigendum

  • You have access
    Corrigendum
    Anticancer Research September 2022, 42 (9) 4657;
Back to top
PreviousNext

In this issue

Anticancer Research: 42 (9)
Anticancer Research
Vol. 42, Issue 9
September 2022
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)

Issue highlights

  • Establishment of Cytotoxic and Non-cytotoxic NK-92 Cell Clones – Evaluation of Their Function as Target Cells
  • Expanding Sorafenib Treatment for Hepatocellular Carcinoma Beyond Barcelona Clinic Liver Cancer Stage C Patients: A National Study
  • An In Vivo Study of Local Administration of Low-dose Anti-PD-1 Antibody Using an Oral Cancer Cell Line
  • Etoposide-induced MicroRNA-205-5p Suppresses Proliferation and Migration by Targeting ERBB4 in MCF-7 Cells
  • Immunological and Genetic Characterization of Patients With Head and Neck Cancer who Developed Recurrence
Sign up for alerts

Jump to

  • Reviews
  • Experimental Studies
  • Clinical Studies
  • Corrigendum
  • Top Topics
  • Most Cited
  • Most Read
Loading
Role of Resveratrol in Prevention and Therapy of Cancer: Preclinical and Clinical Studies
The Association of Solar Ultraviolet B (UVB) with Reducing Risk of Cancer: Multifactorial Ecologic Analysis of Geographic Variation in Age-adjusted Cancer Mortality Rates
Epithelial−Mesenchymal Transition in EGFR-TKI Acquired Resistant Lung Adenocarcinoma
Vitamin D Supplement Doses and Serum 25-Hydroxyvitamin D in the Range Associated with Cancer Prevention
Anticancer Research

© 2023 Anticancer Research

Powered by HighWire